Long-term Cardiovascular Toxicity in Children, Adolescents, and

Pathophysiological interplay heart-cancer disease in patients naïve to

Cumulative incidence of heart failure for cardiotoxic treatment

Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association

Frontiers Cardiotoxicity of Anthracyclines

SEOM clinical guidelines on cardiovascular toxicity (2018)

Mechanism of anthracycline-induced cardiotoxicity. Anthracyclines (A)

Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key? - eBioMedicine

Late Effects of Treatment for Childhood Cancer (PDQ®) - NCI

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity - ScienceDirect

Childhood Obesity and Cardiovascular Disease Risk: Working Toward Solutions - Canadian Journal of Cardiology

Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy

Late effects of cancer in children, teenagers and young adults: Population-based study on the burden of 183 conditions, in-patient and critical care admissions and years of life lost - The Lancet Regional

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review - ScienceDirect

Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions